No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs78014109 |
chr19:41337302-41337303 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs148434100 |
chr19:41337332-41337333 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs143953879 |
chr19:41337416-41337417 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs145952590 |
chr19:41337450-41337451 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs538753740 |
chr19:41337460-41337461 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs562781699 |
chr19:41337496-41337497 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs577811918 |
chr19:41337497-41337498 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs545150353 |
chr19:41337512-41337513 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs187535452 |
chr19:41337567-41337568 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs560993887 |
chr19:41337578-41337579 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs529838491 |
chr19:41337601-41337602 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs543469712 |
chr19:41337622-41337623 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs560697205 |
chr19:41337701-41337702 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs557958601 |
chr19:41337728-41337729 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs550093285 |
chr19:41337762-41337763 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs571516705 |
chr19:41337772-41337773 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs139751720 |
chr19:41337775-41337776 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs547575240 |
chr19:41337800-41337801 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs193278068 |
chr19:41337820-41337821 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs114680880 |
chr19:41337830-41337831 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs185429902 |
chr19:41337836-41337837 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs190266468 |
chr19:41337843-41337844 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs377113772 |
chr19:41337866-41337867 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs191878085 |
chr19:41337884-41337885 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs184315813 |
chr19:41337893-41337894 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs11879413 |
chr19:41337923-41337924 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs545210088 |
chr19:41337976-41337977 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs188698044 |
chr19:41338047-41338048 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs572131357 |
chr19:41338048-41338049 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs542339628 |
chr19:41338071-41338072 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs560981855 |
chr19:41338086-41338087 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs8107294 |
chr19:41338183-41338184 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs3852867 |
chr19:41338202-41338203 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs565189625 |
chr19:41338226-41338227 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs181137433 |
chr19:41338235-41338236 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs141028140 |
chr19:41338256-41338257 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs149829169 |
chr19:41338293-41338294 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs3852868 |
chr19:41338372-41338373 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs58888527 |
chr19:41338373-41338374 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs11429581 |
chr19:41338445-41338446 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs71173686 |
chr19:41338462-41338463 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs185179312 |
chr19:41338513-41338514 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs3865453 |
chr19:41338556-41338557 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs533110280 |
chr19:41338583-41338584 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs2431409 |
chr19:41338611-41338612 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs375733094 |
chr19:41338612-41338613 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs189058837 |
chr19:41338621-41338622 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs182447710 |
chr19:41338628-41338629 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs186994923 |
chr19:41338631-41338632 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs571626767 |
chr19:41338653-41338654 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|